SYP and Alzheimer disease: Interestingly, although preliminary, we found that both APache and AP-2 levels were severely reduced in late-onset sporadic AD patients, while presynaptic markers such as the SV-associated proteins synaptophysin and synaptotagmin1 were still normal (Fig. S5 C, D).